AHSG and metabolic dysfunction-associated steatohepatitis: Both preclinical and clinical research have demonstrated that elevated fetuin-A level is an indicator for several metabolic illnesses, such as obesity, T2D, NAFLD, NASH, IR, etc. [48, 49], which in turn cause several hepatic-related complications to progress to cirrhosis [50].